Ep. 76: Jay Jacobs: These High-Growth ETF Themes Have Seen Double-Digit Returns In Coronavirus Rally
Investing With IBD
00:00
Genomics and the Global XETF: COVID-19
Genomics has been there from the beginning with COVID-19. Once you scale testing, then you can start to develop treatments. A lot of creating the vaccine is going to be done based off of the modeling of the genome of the virus that we already have. There are a few ideas that really are worth considering adding your watch list.
Transcript
Play full episode
